Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-24 @ 6:59 PM
NCT ID:
NCT04828057
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent obtained before any study-related activities (study-related activities are any procedure related to extraction of data according to the protocol)
* According to the approved indications of Tafluprost / Timolol as indicated in the SPC
* Male or female patients ≥20 years of age at time of informed consent
* Diagnosis of open angle glaucoma or ocular hypertension
* Insufficient IOP control with a monotherapy utilizing topical prostaglandin analogues, necessitating the use of a combination therapy according to the judgement of the treating ophthalmologist
* Patient judged by their physician to benefit from preservative free eye drops
* Not used Tafluprost / Timolol before
Exclusion Criteria:
* Patient pregnant or nursing
* Pregnancy planned in the following 6 months
* Presence of contraindications as listed in the SPC
* Any ophthalmologic surgery within 6 months prior to the study
* Participation in any other investigational study within 30 days prior to enrolment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT04828057
Study Brief:
Protocol Section:
NCT04828057